Explore more publications!

California Health Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California Health Watch.

Press releases published on October 16, 2025

PBC Research Foundation and PBCers Form the PBC North American Alliance to Advance Advocacy, and Research in PBC
Verge Genomics to Auction AI and Genomics Drug Discovery Assets via Silicon Valley Disposition (SVD)
Phase Advance and QNova Capital Forge Alliance to Usher in AI-Driven, Non-Animal Drug Development Era
xCures Launches AI-Powered Clinical Checklists 2.0
NXTSTIM’s EcoAI™ Backed by Largest 24-Month Real-World Dataset in Pain Therapy
Institute of Pediatric Sleep and Parenting Reviews Highlight Unmatched Student Success and Industry Trust
LuggageToShip.com Expands ‘Travel and Pay’ Platform to Simplify Global Travel
AVITA Medical Announces CEO Transition
NovelWise Pharmaceutical Receives FDA Fast Track Designation for NBM-BMX in Metastatic Uveal Melanoma
Disc Medicine Announces Receipt of FDA Commissioner’s National Priority Voucher (CNPV) for Bitopertin in Erythropoietic Protoporphyria (EPP)
Lexeo Therapeutics Announces Proposed Offering of Common Stock and Pre-Funded Warrants
Teleflex Announces Third Quarter 2025 Earnings Conference Call Information and Vascular Intervention Investor Virtual Meeting Details
Globus Medical Schedules Third Quarter Earnings Release and Conference Call
atai Life Sciences Announces Proposed Public Offering of Common Shares
atai Life Sciences and Beckley Psytech Announce U.S. FDA Breakthrough Therapy Designation Granted to BPL-003, Underscoring its Potential in Treatment-Resistant Depression
WORK Medical Technology Group LTD Announces 1-for-100 Reverse Stock Split Effective October 21, 2025
LifeStance to Host Third Quarter 2025 Earnings Conference Call on November 6, 2025
Lite Strategy Celebrates 14th Anniversary of Litecoin, Taps Institutional Signals Ahead of 2026
RxSight, Inc. to Feature Live Learning Sessions at American Academy of Ophthalmology 2025 Annual Meeting
Artiva Biotherapeutics Announces Refractory Rheumatoid Arthritis as Lead Indication, Upcoming Data Releases, and Corporate Update

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions